The medical technology company Sensodetect's wholly owned subsidiary Shengde has entered into an investment agreement regarding its Chinese joint venture Beijing Mind Exploration Medical Technology. This is stated in a press release. According to the agreement, an external investor will invest 6.0 million Chinese yuan, equivalent to 7.8 million kronor, in the JV company. The working capital will be used to strengthen the JV company's financial conditions and its capacity to carry out the planned regulatory and commercial process in China.According to the investment agreement, the external investor, after the capital increase has been completed, will own 9.0909 percent of the JV company. As a result of the investment, Sensodetect's indirect ownership stake via Shengde will be adjusted from 20.0 percent to 15.4545 percent in the JV company.The changed ownership structure affects future payments from the JV company that are based on the owners' respective ownership stakes. The effect concerns only possible future revenues after a potential NMPA approval and subsequent commercialization. The ongoing license revenues of 400,000 kronor per month, which are payable under the current license agreement, are not affected. At the same time, Sensodetect assesses that the strengthened financing of the JV company improves the conditions for effective execution and long-term value creation in the Chinese market.